Dr. Musharraf Jelani is a Professor of Molecular Biology and Genetics at the Institute of Basic Medical Sciences, Khyber Medical University (KMU), Peshawar. A dedicated scientist and academic leader, his career is defined by a commitment to advancing the understanding, diagnosis, and management of hereditary disorders, with a profound focus on the populations of Khyber Pakhtunkhwa.

He earned his PhD in Human Molecular Genetics from Quaid-I-Azam University, Islamabad, and launched his academic career at KMU. His expertise was further honed during a significant tenure (2012-2018) at King Abdulaziz University, Jeddah, where he served as a faculty member and Research Associate at the prestigious Princess Al-Jawhara Al-Brahim Centre of Excellence. In this role, he specialized in the molecular diagnostics of rare diseases and supervised cutting-edge research projects.

Upon his return to Pakistan, Dr. Jelani served as an Associate Professor and Director of the Centre for Omic Sciences at Islamia College Peshawar, where he provided the strategic vision to launch pioneering academic programs in Genetics and Molecular Biology.

Dr. Jelani’s research is both impactful and translational. He has pioneered the establishment of molecular diagnostics for over 300 genetic disorders prevalent within the Pakhtun ethnicity, creating an essential resource for the region. At KMU, he leads diagnostic services for Beta-thalassemia and rare genetic conditions affecting multiple clinical specialties, including Ophthalmology, Neurology, and Cardiology. His investigative work has directly contributed to the landmark discovery of seven novel genes causing rare neurodevelopmental and dermatological diseases, expanding the global genetic lexicon.

As a mentor, he is deeply invested in cultivating future scientists, having successfully supervised over 40 MPhil and PhD scholars. Dr. Jelani’s work synthesizes advanced genomic diagnostics, groundbreaking discovery, and academic leadership, dedicated to improving patient outcomes and building national capacity in the field of medical genetics.